Randomized Prospective Phase III Trial of Difluoromethylornithine vs Placebo in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer.
Messing, Edward *,+; Kim, Kyung Mann; Sharkey, Francis; Schultz, Melissa; Parnes, Howard; Kim, Daniel; Saltzstein, Daniel; Wilding, George
Journal of Urology.
176(2):500-504, August 2006.
(Format: HTML, PDF)